Use of dimethicone to reduce the fall in gastric potential difference induced by bile salts

Eur J Clin Pharmacol. 1989;36(4):379-81. doi: 10.1007/BF00558299.

Abstract

The gastric potential difference (PD) was measured in ten healthy volunteers after sodium taurocholate intake. This bile salt was given after treatment with dimethicone or placebo in a cross-over design study. With dimethicone the fall in PD was lower (16.1 vs. 24.8 mV,) and shorter (32.5 vs. 51.0 min) than with the placebo. Our result suggests that the silicone can prevent the formation of the gastric lesions induced by bile salts.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Bile Acids and Salts / pharmacology*
  • Female
  • Humans
  • Male
  • Random Allocation
  • Silicones / pharmacology*
  • Simethicone / pharmacology*
  • Stomach / drug effects
  • Stomach / physiology*
  • Taurocholic Acid / pharmacology
  • Taurodeoxycholic Acid / pharmacology

Substances

  • Bile Acids and Salts
  • Silicones
  • Taurodeoxycholic Acid
  • Taurocholic Acid
  • Simethicone